PURCHASE, NY, Sept. 18, 2023 (GLOBE NEWSWIRE) -- In new research released today by Teladoc Health (NYSE: TDOC), the global leader in whole-person virtual care, U.S. employers with 2,500 or more employees reported a 21% increase in the implementation of additional virtual care offerings over the past 18 months, with 77% stating they plan to increase their investment in virtual care over the next three years.
The findings are part of the company’s second annual Virtual Care Transformation Index, a survey of more than 300 human resource decision makers that highlights the perception, adoption and advancement of whole-person virtual healthcare in benefits programs.
“For employers, the stakes are high when it comes to making sure quality healthcare is always within reach,” said Kelly Bliss, Teladoc Health US Group Health President. “When we first initiated this study, employers were only starting to realize the value and potential of a whole-person virtual care strategy. Amidst continued workforce pressures and economic uncertainty, employers expect to build integrated, high value benefits strategies that fit the diverse needs of their entire population. The study found notable growth in the percentage of employers offering a broader suite of virtual care services and reinforced employers’ desire to manage a minimal number of vendors who can offer comprehensive services. Compared to last year, today’s employers are expected to build innovative, high-value benefits strategies within the context of even more challenging market trends.”
The data from the Virtual Care Transformation Index comes from a survey of more than 326 human resource decision-makers at large and mid-size companies with more than 2,500 employees and will be discussed in greater detail during a webinar on September 19, 2023, with Kelly Bliss and Dr. Alexander Alonzo, SHRM Chief Knowledge Officer. The survey was conducted on behalf of Teladoc Health in June 2023 by TRC Market Research. Additional details are available here.
About Teladoc Health
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Teladoc Health leverages more than two decades of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals. For more information, please visit www.teladochealth.com
Contact
Carolyn Edwards
This email address is being protected from spambots. You need JavaScript enabled to view it.
+1 321-795-1952
Last Trade: | US$9.99 |
Daily Change: | 0.06 0.60 |
Daily Volume: | 4,122,613 |
Market Cap: | US$1.720B |
November 25, 2024 October 30, 2024 July 31, 2024 July 16, 2024 |
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREChimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREEnd of content
No more pages to load